Related Experiment Video

Updated: Jul 6, 2026

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients

Hara Levy1, Leslie A Kalish, Carolyn L Cannon

  • 1Division of Pulmonary Medicine, Children's Hospital, Boston, Massachusetts, USA. hlevy@mcw.edu

Pediatric Pulmonology
|March 26, 2008
PubMed
Abstract

Insights

Female gender, more DF508 alleles, and poorer lung function increase the risk of mucoid Pseudomonas aeruginosa in cystic fibrosis patients. Early detection of these risk factors is crucial for timely intervention.

Area of Science:

  • Medical research
  • Pulmonology
  • Infectious diseases

Background:

  • Chronic mucoid Pseudomonas aeruginosa infection significantly impacts cystic fibrosis (CF) prognosis.
  • Identifying risk factors for mucoid P. aeruginosa acquisition is vital for improving CF patient care.

Purpose of the Study:

  • To evaluate risk factors associated with mucoid P. aeruginosa acquisition in CF patients.
  • Investigate the role of gender, CFTR genotype, other bacterial infections, and serum biomarkers in predicting mucoid P. aeruginosa infection.

Main Methods:

  • Longitudinal study analyzing Cox proportional hazards regression with time-dependent covariates.
  • Primary endpoint: age at first positive culture for mucoid P. aeruginosa.
  • Evaluated associations with serum biomarkers, pulmonary function (FEV1%), and other microbial cultures.

Main Results:

  • 150 out of 323 subjects acquired mucoid P. aeruginosa during follow-up.
  • Significant risk factors identified: female gender (RH 0.55), number of DF508 alleles (RH 1.66), decreased FEV1% (RH 1.16), and absence of Staphylococcus aureus (RH 0.24).

Conclusions:

  • Female sex, increased DF508 alleles, reduced lung function, and lack of S. aureus are key predictors of mucoid P. aeruginosa.
  • These findings aid in early detection and targeted management strategies for CF patients.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...